High levels of circulating cell-free DNA are a biomarker of active SLE.
Yalan XuYijun SongJiazhen ChangXiya ZhouQingwei QiXinping TianMengtao LiXiaofeng ZengMengnan XuWenjuan ZhangDavid S CramJuntao LiuPublished in: European journal of clinical investigation (2018)
Our results suggest that in addition to classical SLE serological markers, measurement of circulating plasma cfDNA levels has potential as a useful biomarker for assessing SLE disease activity in patients and monitoring treatment.
Keyphrases